Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber

PURPOSE: To report patient demographics, the clinical course, and visual outcomes across a case series of patients who experienced dexamethasone (DEX) intravitreal implant (Ozurdex, Allergan, Inc) migration into the anterior chamber (AC), with a focus on the corneal transplantation rate. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Betsch, Devin M., Gupta, R. Rishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscripts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954786/
https://www.ncbi.nlm.nih.gov/pubmed/37009539
http://dx.doi.org/10.1177/24741264221138166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954786/
https://www.ncbi.nlm.nih.gov/pubmed/37009539
http://dx.doi.org/10.1177/24741264221138166

Ejemplares similares